Venous Irregularities, Flow and Perfusion in MS Study (VERIFYMS)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2012 by Synergy Health Concepts, Inc..
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Synergy Health Concepts, Inc.
ClinicalTrials.gov Identifier:
NCT01593904
First received: May 6, 2012
Last updated: NA
Last verified: May 2012
History: No changes posted

May 6, 2012
May 6, 2012
January 2012
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Venous Irregularities, Flow and Perfusion in MS Study
Venous Irregularities, Flow and Perfusion in MS Study
  1. What is the true incidence of CCSVI in patients with MS in a study comparing MRI on MS patients and controls.
  2. Are the beneficial outcomes from treatment placebo? By measuring changes in brain perfusion and Cerebrospinal flow before and after the procedure on a large number of patients to determine these outcomes

The purpose of this study is to compare a MS subject to a non-MS, non-blood related subject. The 3D structural information provided by the protocol combined with the ability to observe and quantify flow through the major vessels of the neck, as well as the azygous vein, make it an ideal method for evaluating subjects' venous outflow. The protocol also has the potential to confirm the diagnosis of Multiple Sclerosis, observe any changes in the parenchyma, as well as provide data on any potential co-morbidity which may have been previously overlooked or non-emergent. The baseline scan data acquired on normal and pre-treatment MS patients can be tracked longitudinally for MSpatients for changes in: arterial and venous cross sectional area; morphological changes of vessels, brain structures, and lesions; flow distribution and flow patterns in arteries, veins, and cerebrospinal fluid (CSF); iron quantification in the deep basal ganglia and thalamus; parenchymal lesion volume and morphology; atrophy or ratio of gray matter, white matter; and CSF in the intracranial space; and appearance of intracranial veins and potential iron lesions in the parenchyma. A major benefit is that MRI is independent of operator bias and acquisition can be easily reproduced.

Observational
Observational Model: Case Control
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample

Human subjects will be approached for participation in this study that are receiving or seeking medical care at Synergy Health Concepts Inc.

Venous Irregularities, Flow and Perfusion in MS and Non-MS Participants
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
400
January 2013
Not Provided

Inclusion Criteria:

  • Ability to comprehend the nature of the study, including the risks and benefits
  • Ability to execute an informed consent
  • Males or Females between the ages of 20 and 65 years of age
  • Voluntary agreement to participate in the study: Venous Irregularities, Flow and Perfusion in MS study (VERIFY MS Study)

Exclusion Criteria:

  • Any implantable/metallic objects that prevents subject from having a magnetic resonance imaging (MRI/MRV) study.
  • Any person who has a contraindication to contrast administration.
  • History of claustrophobia
  • Special Populations. Special groups include, but are not limited to children, prisoners, pregnant women, fetuses, and cognitively impaired individuals who are unable to provide informed consent
Both
20 Years to 65 Years
Yes
Contact: Frances Debarge- Igoe, RN (949) 221-0129 uscangionurse@gmail.com
Contact: John Joseph Hewett, MD (949) 221-0129 jhewett@synergyhealthconcepts.com
United States
 
NCT01593904
VERIFYMS
Yes
Synergy Health Concepts, Inc.
Synergy Health Concepts, Inc.
Not Provided
Principal Investigator: John Joseph Hewett, MD Study Principal Investigator
Synergy Health Concepts, Inc.
May 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP